ADC Therapeutics SA (ADCT) earnings · rev $40.1M
ADC Therapeutics SA (ADCT) is a biotechnology company listed on NYSE.
This ADCT earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ADCT revenue for 2026-06-30 was $40.1M. Net income was -$49.5M. Revenue was up 92.3% from 2026-03-31 to 2026-06-30. ADCT currently screens at market cap $141.2M.
When the next ADCT 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 92.3% from 2026-03-31 to 2026-06-30. An earnings headline that ignores that move is noise.
Not investment advice. Full ADCT research stays on the stock page; the tape stays on the quote page.
Not investment advice.